The yield of immediate post lung biopsy CT in predicting iatrogenic pneumothorax.


Journal

BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563

Informations de publication

Date de publication:
15 Apr 2020
Historique:
received: 10 10 2019
accepted: 31 03 2020
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 26 1 2021
Statut: epublish

Résumé

The most prevalent complication of percutaneous lung biopsy is pneumothorax (PNX). A routine immediate post-procedure CT scan (ICT) to spot PNX is done in many centers. However, the diagnostic yield of this practice has not been studied broadly. We sought to evaluate whether an ICT could replace the routine follow-up chest X-ray (CXR) in detecting procedure related PNX. We examined case-records of 453 patients who underwent lung biopsy at our medical center. We analyzed findings from CXR performed 2-h after biopsy and from CT images at the site of biopsy acquired immediately after the procedure (ICT). Multivariate analysis was used to identify the risk factors for PNX, and we examined the concordance between ICT and CXR-2-h post-procedure. A total of 87 patients (19%) were diagnosed with PNX on CXR-2-h post-procedure. ICT detected 80.5% of diagnosed PNX (p <  0.01). However, ICT demonstrated a negative predictive value of only 94%, meaning 17 patients (6%) with a negative ICT did eventually develop PNX seen on CXR. Furthermore, bleeding surrounding the puncture area spotted on ICT negatively predicted the development of PNX (OR = 0.4 95% CI; 0.2-0.7). We conclude that a CT scan performed immediately after percutaneous lung biopsy cannot replace the routine follow-up CXR in predicting iatrogenic PNX. Bleeding in the needle's tract may lower the risk for procedure-related PNX.

Sections du résumé

BACKGROUND BACKGROUND
The most prevalent complication of percutaneous lung biopsy is pneumothorax (PNX). A routine immediate post-procedure CT scan (ICT) to spot PNX is done in many centers. However, the diagnostic yield of this practice has not been studied broadly. We sought to evaluate whether an ICT could replace the routine follow-up chest X-ray (CXR) in detecting procedure related PNX.
METHODS METHODS
We examined case-records of 453 patients who underwent lung biopsy at our medical center. We analyzed findings from CXR performed 2-h after biopsy and from CT images at the site of biopsy acquired immediately after the procedure (ICT). Multivariate analysis was used to identify the risk factors for PNX, and we examined the concordance between ICT and CXR-2-h post-procedure.
RESULTS RESULTS
A total of 87 patients (19%) were diagnosed with PNX on CXR-2-h post-procedure. ICT detected 80.5% of diagnosed PNX (p <  0.01). However, ICT demonstrated a negative predictive value of only 94%, meaning 17 patients (6%) with a negative ICT did eventually develop PNX seen on CXR. Furthermore, bleeding surrounding the puncture area spotted on ICT negatively predicted the development of PNX (OR = 0.4 95% CI; 0.2-0.7).
CONCLUSIONS CONCLUSIONS
We conclude that a CT scan performed immediately after percutaneous lung biopsy cannot replace the routine follow-up CXR in predicting iatrogenic PNX. Bleeding in the needle's tract may lower the risk for procedure-related PNX.

Identifiants

pubmed: 32293380
doi: 10.1186/s12890-020-1128-8
pii: 10.1186/s12890-020-1128-8
pmc: PMC7158108
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

91

Références

Insights Imaging. 2017 Aug;8(4):419-428
pubmed: 28639114
Thorax. 2003 Nov;58(11):920-36
pubmed: 14586042
Chest. 2004 Nov;126(5):1516-21
pubmed: 15539721
Semin Intervent Radiol. 2011 Mar;28(1):87-97
pubmed: 22379279
Eur Radiol. 2018 Mar;28(3):1328-1337
pubmed: 28971242
BMC Pulm Med. 2018 Sep 3;18(1):146
pubmed: 30176840
Eur Radiol. 2017 Jan;27(1):138-148
pubmed: 27108299
PLoS One. 2017 Jun 2;12(6):e0178078
pubmed: 28574995
Biomed Res Int. 2019 May 5;2019:7857310
pubmed: 31192257
J Thorac Dis. 2014 Mar;6 Suppl 1:S99-S107
pubmed: 24672704
AJR Am J Roentgenol. 1986 May;146(5):1049-50
pubmed: 3485899
J Med Imaging Radiat Oncol. 2011 Oct;55(5):474-8
pubmed: 22008165
Cardiovasc Intervent Radiol. 2017 Sep;40(9):1415-1420
pubmed: 28432386

Auteurs

Rafael Y Brzezinski (RY)

Department of Internal Medicine "C", "D" and "E", Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Neufeld Cardiac Research Institute, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Tamman Cardiovascular Research Institute, Leviev Heart Center, Sheba Medical Center, Tel-Hashomer, Israel.

Ifat Vigiser (I)

Department of Neurology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Irina Fomin (I)

Division of Pulmonary Medicine, Barzilai Medical Center, Faculty of Health Sciences, Ben-Gurion University, 2 Hahistadrut Street, Ashkelon, Israel.

Lilach Israeli (L)

Division of Pulmonary Medicine, Barzilai Medical Center, Faculty of Health Sciences, Ben-Gurion University, 2 Hahistadrut Street, Ashkelon, Israel.

Shani Shenhar-Tsarfaty (S)

Department of Internal Medicine "C", "D" and "E", Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Amir Bar-Shai (A)

Division of Pulmonary Medicine, Barzilai Medical Center, Faculty of Health Sciences, Ben-Gurion University, 2 Hahistadrut Street, Ashkelon, Israel. amirb@bmc.gov.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH